Abstract
The purpose of this study was to find out what proportion of patients are referred as lung cancer guidelines assume, whether different referral pathways result in different management and what proportion of patients are seen within recommended time intervals between referral and treatment. A randomly selected sample of 400 lung cancer cases registered with the former Yorkshire Cancer Registry database in 1993 was selected for casenote analysis. Mode of presentation, speciality of initial referral, treatment by specialist, time intervals for key points in the referral pathways were analyzed. A total of 362 (90.5%) of case-notes were available. Less than half of lung cancer patients (173, 47.8%) presented to hospital with a chest X-ray diagnosis of lung cancer. Forty-one (11.3%) presented as self-referrals to Accident and Emergency and the remainder were referred without a diagnosis of lung cancer by other routes, mainly via GPs. Patients who did not present initially with a lung cancer diagnosis were less likely to receive specialist care (62%:96%), or have their diagnosis histologically confirmed (57.1%:80.3%) or receive surgery or radical radiotherapy (6.9%:13.9%). Nine per cent of all 362 patients did not receive a specialist opinion. Eighty per cent of patients referred by a GP with CXR suspected lung cancer were seen at hospital within 2 weeks. Only 32.4% of those receiving active treatment were treated within 8 weeks of clinical diagnosis or first hospital visit. Lung cancer patients presenting to hospital without a suspicious CXR are less likely to have specialist care, histological confirmation of their cancer and have lower rates of active treatment (surgery, any radiotherapy or chemotherapy).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Billing JS, Wells MC (1996) Delays in the diagnosis and surgical treatment of lung cancer. Thorax 51: 903–906
Brown JS, Eraut D, Trask C, Davison AG (1996) Age and the treatment of lung cancer. [see comments]Thorax 51: 6 564–568
BTS (1998) The lung cancer working party of the British Thoracic Society (BTS). British Thoracic Society recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax 53: Suppl 1 1–8
Cancer Outcomes Monitoring (1999) Cancer treatment policies and their effects on survival: Lung. Key sites study 2 NYCRIS. (available at www.nycris.org.uk)
Cancer Outcomes Monitoring (2000) Lung Cancer Referral Patterns: The Yorkshire Experience NYCRIS (available at www.nycris.org.uk)
Crawford SM, Atherton F (1994) Lung cancer: histological aspects of diagnosis in England and the south east Netherlands. J Epi Comm Health 48: 420
Dische S, Gibson D, Parmar M, Saunders MI (1996) Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee. Thorax 51: 12 1262–1265
DoH (1997) The New NHS – Modern and Dependable HMSO
DoH (1999) Referral guidelines for suspected cancer – consultation document November 1999 Department of Health (DoH)
Fergusson RJ, Gregor A, Dodds R, Kerr G (1996) Management of lung cancer in South East Scotland. Thorax 51: 6 569–574
Fergusson RJ, Milroy R, Brown P, Gregor A, Jones R, Stroner PL (1999) Lung cancer in Scotland – Importance of seeing a chest physician. Thorax 54: S3 A34
Gregor A, Stroner PL, Davidson, Thomson CS (1999) Lung Cancer in Scotland – the 1995 reality. Br J Cancer 80: S2 15
Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, Milroy R on behalf of the Scottish Cancer Trial Lung Group and the Scottish Cancer Therapy Network (2001) Management and survival of lung cancer patients diagnosed in 1995 in Scotland: results of a national, population based study. Thorax 56: 212–217
Janssen-Heijnen MLG, Gatta G, Forman D and the EUROCARE Working group (1998) Variation in survival of patients with lung cancer in Europe, 1985–1989. Eur J Cancer 34: 14 2191–2196
Kesson E, Bucknall CE, McAlpine LG, Milroy R, Hole D, Vernon DR, Macbeth F, Gillis CR (1998) Lung cancer–management and outcome in Glasgow, 1991-92. Br J Cancer 78: 10 1391–1395
Muers MF, Haward RA (1996) Management of lung cancer. Thorax 51: 557–560
NHSE (1998) Guidance on commissioning cancer services: Improving outcomes in lung cancer NHSE
Nugent WC, Edney MT, Hammerness PG, Dain BJ, Maurer LH, Rigas JR (1997) Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment. Annals of Thoracic Surgery 63: 193–197
Office for National Statistics (ONS, 1998) 1992 Cancer statistics registrations: England and Wales London: The Stationery Office
Pickles H, Rudolf M (1998) Lung cancer: local review of services. Thorax 53: Suppl 3 A57
Richardson GE, Thursfield VJ, Giles GG (2000) Reported management of lung cancer in Victoria in 1993 – comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Australia 172: 7 321–324
Scottish Intercollegiate Guidelines Network (SIGN, 1998) Management of Lung cancer Edinburgh: SIGN Publication No 23
SMAC (1994) Management of lung cancer: current clinical practices (Whitehouse Report) Standing Medical Advisory Committee (SMAC)
Spurgeon P, Barwell F, Kerr D (2000) Waiting times for cancer patients in England after General Practitioners' referrals: retrospective national survey. BMJ 320: 838–839
Thompson SL, Lowe D, Peake MD, Pearson MG on behalf of participating hospitals (1999) RCP Lung cancer audit – Factors associated with poor 6 month survival in non-small cell cancer. Thorax 54: Suppl 3 A14
Turner NJ, Haward RA, Mulley GP, Selby PJ (1999) Cancer in old age is it inadequately investigated and treated? BMJ 319: 7205 309–312
Acknowledgements
We thank Mr ME Cowen, Dr M Bond, Dr CK Connolly, Dr D Parker and Dr HR Gribbin for their participation in the study design and Ms Ros Collins for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melling, P., Hatfield, A., Muers, M. et al. Lung cancer referral patterns in the former Yorkshire region of the UK. Br J Cancer 86, 36–42 (2002). https://doi.org/10.1038/sj.bjc.6600029
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600029
Keywords
This article is cited by
-
Social and geographical factors affecting access to treatment of lung cancer
British Journal of Cancer (2009)
-
Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients
British Journal of Cancer (2003)
-
Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?
British Journal of Cancer (2003)